Chonluten Research Guide

Overview

Chonluten (also referenced in the literature as T-34 or the EDG tripeptide) is the trade designation for the synthetic tripeptide Glu-Asp-Gly (EDG), a member of the peptide bioregulator class originally developed through Russian gerontological and molecular biology research programs. Structurally, Chonluten consists of three amino acid residues — glutamic acid, aspartic acid, and glycine — joined in a linear sequence, with a molecular formula of approximately C₁₁H₁₇N₃O₈ and a molecular weight of approximately 319.3 g/mol (CAS 75007-24-8).

Chonluten belongs to a broader family of short peptide bioregulators, sometimes referred to as “Khavinson peptides” after the research group most closely associated with their development, which also includes related short peptides studied for tissue-specific regulatory activity. Within this class, Chonluten (EDG) has been studied specifically in relation to bronchial epithelial cells and respiratory tissue biology. This guide focuses exclusively on published bronchial- and respiratory-tissue-related research findings rather than usage protocols. Available for research at Iron Peak Peptides: Chonluten.

The bioregulator peptide concept, as developed in this research tradition, is built on the premise that very short peptides — typically two to seven amino acid residues in length — can exert tissue-selective regulatory effects that are distinct from the receptor-mediated signaling mechanisms associated with larger signaling peptides and growth factors. Chonluten is one of a series of such short peptides studied for organ- or tissue-specific activity, with bronchial epithelium and respiratory tissue identified as its primary area of research interest, distinguishing it from other bioregulator peptides in the same structural family that have instead been studied in relation to cartilage, skin, or cardiovascular tissue.

Mechanism of Action

Short peptide bioregulators such as Chonluten are proposed to act, at least in part, through direct interaction with nuclear chromatin. Published biophysical and molecular modeling research on this peptide class describes short peptides binding to specific nucleotide sequences within DNA promoter regions and interacting with histone proteins through hydrogen bonding and electrostatic interactions. This DNA- and histone-binding activity has been proposed as a mechanism by which short regulatory peptides influence gene transcription and epigenetic states associated with tissue-specific cellular function (Khavinson et al., 2021).

In cell-based immunology research, Chonluten has been examined as one of several Khavinson-class peptides evaluated for effects on proliferative and inflammatory signaling in monocyte and macrophage cell models. Published in vitro research using the human THP-1 monocytic cell line reported that Chonluten treatment was associated with increased tyrosine phosphorylation of mitogen-activated cytoplasmic kinases, phosphorylation of STAT1 and STAT3 transcription factors, and — notably — inhibition of tumor necrosis factor (TNF) production by monocytes exposed to bacterial lipopolysaccharide (LPS), a mechanism the study authors associated with a form of TNF tolerance and attenuated inflammatory signaling (Avolio et al., 2022). These findings have been discussed in the context of Chonluten’s original tissue-of-origin association with bronchial epithelial cells, a tissue type in which local inflammatory and immune cell signaling is of particular research interest.

Published Research

Published research on Chonluten and the broader short-peptide bioregulator class provides converging evidence for a role in respiratory tissue and immune cell regulation, situated within a larger body of work on peptide-mediated gene expression.

Avolio and colleagues evaluated Chonluten alongside four other Khavinson-class peptides (Epitalon, Vilon, Thymogen, and Thymalin) in the human THP-1 monocyte/macrophage cell line, examining proliferative and inflammatory signaling pathways. The study reported that Chonluten, described by the authors as derived from bronchial epithelial cells, inhibited in vitro TNF production by monocytes exposed to pro-inflammatory bacterial lipopolysaccharide, and that Chonluten treatment was associated with activation of STAT1 phosphorylation in macrophage-differentiated THP-1 cells, alongside reduced cell-adhesion markers in a monocyte-endothelial cell co-culture assay (Avolio et al., 2022).

Khavinson and colleagues, in a systematic review of peptide regulation of gene expression, described the molecular basis by which short peptides of two to seven amino acid residues interact with nucleosomes, histone proteins, and single- and double-stranded DNA, situating short bronchial-tissue-associated peptides such as Chonluten within this broader mechanistic framework of tissue-selective transcriptional regulation (Khavinson et al., 2021).

Earlier foundational work by Anisimov and Khavinson summarized several decades of research into peptide bioregulation of aging, describing a broad experimental and observational research program examining how tissue-specific short peptide bioregulators, administered in various animal models, correlate with markers of biological aging across multiple organ systems, including the respiratory system (Anisimov & Khavinson, 2010).

Complementary review work by Khavinson on peptide regulation of cell differentiation further describes how short peptides can participate in activating signaling pathways that regulate the expression of differentiation-associated genes, including through direct interaction with histone proteins that alter chromatin accessibility — a mechanistic framework applied broadly across the bioregulator peptide family, including tissue-specific peptides such as Chonluten (Khavinson et al., 2020).

Taken together, this literature situates Chonluten within a defined peptide bioregulator research tradition emphasizing epigenetic and transcriptional mechanisms, with bronchial- and respiratory-tissue-specific findings concentrated on monocyte/macrophage inflammatory signaling and cytokine regulation rather than on any single, isolated mechanism of action.

Chemical Properties & Specifications

• Common name: Chonluten (also referenced as T-34 or EDG tripeptide)
• Chemical designation: Glu-Asp-Gly (EDG) tripeptide
• Peptide class: Short peptide bioregulator (bioregulator peptide family)
• Amino acid sequence: Glutamic acid – Aspartic acid – Glycine
• Molecular formula: Approximately C₁₁H₁₇N₃O₈
• Molecular weight: Approximately 319.3 g/mol
• CAS Number: 75007-24-8
• Appearance: White to off-white lyophilized powder
• Storage: Store lyophilized peptide at -20°C, protected from moisture and light. Once reconstituted, solutions should be stored at 2-8°C and used within the timeframe established by the supplying laboratory; repeated freeze-thaw cycling should be avoided to preserve peptide integrity.

Research Applications

Chonluten is used in laboratory research primarily within the fields of respiratory tissue biology, immune cell signaling, and molecular gerontology. Specific research applications include in vitro monocyte and macrophage cell culture studies examining cytokine production (including TNF and IL-6), STAT transcription factor phosphorylation, and cell-adhesion signaling in models of lipopolysaccharide-induced inflammation, as well as broader studies of the peptide bioregulator class’s proposed epigenetic mechanisms, including DNA- and histone-binding activity relevant to tissue-selective gene transcription.

Researchers in the bioregulator peptide field also study Chonluten as part of comparative work examining tissue-selective activity across the broader family of short regulatory peptides, several of which have been associated in the literature with different organ systems, such as the thymus, pineal gland, cartilage, and vasculature. Additional research contexts include biogerontology studies exploring the relationship between short peptide bioregulators and markers of cellular and tissue aging in the respiratory system, and structural biology research using molecular modeling and docking approaches to characterize how short peptides such as Chonluten may interact with DNA and histone targets at the molecular level.

Given the persistent research interest in the molecular biology of bronchial epithelial and pulmonary immune signaling, Chonluten continues to be examined as a tool compound for probing the pathways that govern monocyte and macrophage inflammatory responses, cytokine tolerance mechanisms, and cell-adhesion processes relevant to respiratory tissue research models. Researchers frequently position such short peptide bioregulators alongside other Khavinson-class peptides, including thymic and pineal-derived peptides, when designing comparative in vitro immune cell or ex vivo respiratory tissue models.

References

1. Avolio F, Martinotti S, Khavinson VK, et al. (2022). Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences.
2. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules.
3. Anisimov VN, Khavinson VK. (2010). Peptide bioregulation of aging: results and prospects. Biogerontology.
4. Khavinson V, Linkova N, Diatlova A, et al. (2020). Peptide Regulation of Cell Differentiation. Stem Cell Reviews and Reports.